Login

Paion advancing its general anesthesia drug candidate - Wolfgang Soehngen, CEO, Paion 00:00:00

Share On Facebook Share On Twitter

Paion advancing its general anesthesia drug candidate

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
The Company develops and manufactures liquids gels and creams for topical pain|Jesse Ledger,CEO,Nuvo Pharmaceuticals Inc
00:10:00
Predictive Discovery: Unlocking Gold Potential in West Africa through Strategic Exploration and Partnerships
00:00:00
CEO TALK - Yakov Kogan, CEO, Cleveland BioLabs
00:00:00
Can you prevent cancer with lifestyle changes -Jon O. Ebbert, M.D. Internist, Mayo Clinic
00:10:00
Exclusive Interview with ATFX Chairman Joe Lee at IFX Expo: Technological Innovations and Strategic Vision
00:10:00
Allspring’s vision is to inspire a new era of investing that pursues both financial returns and positive outcomes. Diverse perspectives power our investment strategies through a unified platform and a commitment to our clients.| Joe Sullivan,Chief Executi
00:10:00
Leading Innovation: Mary Barra on The David Rubenstein Show
00:10:00
Aehr Test Systems (AEHR) Stock Up 95% YTD | Gayn Erickson, CEO, Aehr Test SystemsAEHR:NAS
00:10:00
Griffin Gold Corporation: Advancing Mining Prospects in Nevada's Walker Lane Gold Belt
00:10:00
Impact of TCJA Sunset on Gifting Strategies: Insights from Mark Struthers at IWI Conference | Mark Struthers - CFA founder of Sona Wealth
00:10:00
Provenance Gold Corp.: Interview with Rano Patoo on White Rock Project and Expansion Plans
00:10:00
Early-stage fund led by Shana Fischer|Shana Fischer,General Partner,Third Kind Venture Capital

© 2017 - Neuhu+